These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
192 related items for PubMed ID: 28829763
1. Did the addition of concurrent chemotherapy to conventional radiotherapy improve survival for patients with HPV+ve and HPV-ve Oropharynx cancer? A population-based study. Hall SF, Liu FF, O'Sullivan B, Shi W, Rohland S, Griffiths R, Groome P. Br J Cancer; 2017 Oct 10; 117(8):1105-1112. PubMed ID: 28829763 [Abstract] [Full Text] [Related]
2. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. Spreafico A, Huang SH, Xu W, Granata R, Liu CS, Waldron JN, Chen E, Ringash J, Bayley A, Chan KK, Hope AJ, Cho J, Razak AA, Hansen A, Jang R, Perez-Ordonez B, Weinreb I, Bossi P, Orlandi E, Licitra LF, Song Y, O'Sullivan B, Siu LL, Kim J. Eur J Cancer; 2016 Nov 10; 67():174-182. PubMed ID: 27669504 [Abstract] [Full Text] [Related]
4. Impact of human papillomavirus on outcome in patients with oropharyngeal cancer treated with primary surgery. Broglie MA, Stoeckli SJ, Sauter R, Pasche P, Reinhard A, de Leval L, Huber GF, Pezier TF, Soltermann A, Giger R, Arnold A, Dettmer M, Arnoux A, Müller M, Spreitzer S, Lang F, Lutchmaya M, Stauffer E, Espeli V, Martucci F, Bongiovanni M, Foerbs D, Jochum W. Head Neck; 2017 Oct 10; 39(10):2004-2015. PubMed ID: 28691255 [Abstract] [Full Text] [Related]
10. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer. Buglione M, Maddalo M, Corvò R, Pirtoli L, Paiar F, Lastrucci L, Stefanacci M, Belgioia L, Crociani M, Vecchio S, Bonomo P, Bertocci S, Borghetti P, Pasinetti N, Triggiani L, Costa L, Tonoli S, Grisanti S, Magrini SM. Int J Radiat Oncol Biol Phys; 2017 Mar 01; 97(3):462-472. PubMed ID: 27986347 [Abstract] [Full Text] [Related]
11. Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer. Frakes JM, Naghavi AO, Demetriou SK, Strom TJ, Russell JS, Kish JA, McCaffrey JC, Otto KJ, Padhya TA, Harrison LB, Trotti AM, Caudell JJ. Cancer; 2016 Feb 15; 122(4):634-41. PubMed ID: 26565997 [Abstract] [Full Text] [Related]
13. Human papillomavirus DNA and p16 expression in Japanese patients with oropharyngeal squamous cell carcinoma. Kawakami H, Okamoto I, Terao K, Sakai K, Suzuki M, Ueda S, Tanaka K, Kuwata K, Morita Y, Ono K, Nishio K, Nishimura Y, Doi K, Nakagawa K. Cancer Med; 2013 Dec 15; 2(6):933-41. PubMed ID: 24403267 [Abstract] [Full Text] [Related]
16. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y, Park HS, Kelly JR, Stahl JM, Yarbrough WG, Burtness BA, Contessa JN, Decker RH, Koshy M, Husain ZA. Cancer; 2017 Jul 15; 123(14):2762-2772. PubMed ID: 28323338 [Abstract] [Full Text] [Related]
18. Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck. Riaz N, Sherman E, Koutcher L, Shapiro L, Katabi N, Zhang Z, Shi W, Fury M, Wong R, Wolden S, Rao S, Lee N. Am J Clin Oncol; 2016 Feb 15; 39(1):27-31. PubMed ID: 24401670 [Abstract] [Full Text] [Related]
19. Quantitation of human papillomavirus DNA in plasma of oropharyngeal carcinoma patients. Cao H, Banh A, Kwok S, Shi X, Wu S, Krakow T, Khong B, Bavan B, Bala R, Pinsky BA, Colevas D, Pourmand N, Koong AC, Kong CS, Le QT. Int J Radiat Oncol Biol Phys; 2012 Mar 01; 82(3):e351-8. PubMed ID: 21985946 [Abstract] [Full Text] [Related]